vs

Side-by-side financial comparison of California Resources Corp (CRC) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $679.0M, roughly 1.9× California Resources Corp). Dexcom runs the higher net margin — 21.2% vs 1.8%, a 19.5% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -17.8%). Over the past eight quarters, California Resources Corp's revenue compounded faster (25.8% CAGR vs 12.0%).

California Resources Corporation is an American energy corporation engaged in hydrocarbon exploration in California. It is organized in Delaware and headquartered in Long Beach, California. Its mineral acreage holdings in California constitute the largest privately held position in the state.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

CRC vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.9× larger
DXCM
$1.3B
$679.0M
CRC
Growing faster (revenue YoY)
DXCM
DXCM
+39.4% gap
DXCM
21.6%
-17.8%
CRC
Higher net margin
DXCM
DXCM
19.5% more per $
DXCM
21.2%
1.8%
CRC
Faster 2-yr revenue CAGR
CRC
CRC
Annualised
CRC
25.8%
12.0%
DXCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CRC
CRC
DXCM
DXCM
Revenue
$679.0M
$1.3B
Net Profit
$12.0M
$267.3M
Gross Margin
62.9%
Operating Margin
6.9%
25.6%
Net Margin
1.8%
21.2%
Revenue YoY
-17.8%
21.6%
Net Profit YoY
-63.6%
153.6%
EPS (diluted)
$0.21
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRC
CRC
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$679.0M
$1.3B
Q3 25
$715.0M
$1.2B
Q2 25
$702.0M
$1.2B
Q1 25
$814.0M
$1.0B
Q4 24
$826.0M
$1.1B
Q3 24
$870.0M
$994.2M
Q2 24
$412.0M
$1.0B
Net Profit
CRC
CRC
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$12.0M
$267.3M
Q3 25
$64.0M
$283.8M
Q2 25
$172.0M
$179.8M
Q1 25
$115.0M
$105.4M
Q4 24
$33.0M
$151.7M
Q3 24
$345.0M
$134.6M
Q2 24
$8.0M
$143.5M
Gross Margin
CRC
CRC
DXCM
DXCM
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
CRC
CRC
DXCM
DXCM
Q1 26
25.6%
Q4 25
6.9%
25.6%
Q3 25
13.7%
20.1%
Q2 25
38.0%
18.4%
Q1 25
22.9%
12.9%
Q4 24
8.2%
17.0%
Q3 24
59.5%
15.3%
Q2 24
9.2%
15.7%
Net Margin
CRC
CRC
DXCM
DXCM
Q1 26
21.2%
Q4 25
1.8%
21.2%
Q3 25
9.0%
23.5%
Q2 25
24.5%
15.5%
Q1 25
14.1%
10.2%
Q4 24
4.0%
13.6%
Q3 24
39.7%
13.5%
Q2 24
1.9%
14.3%
EPS (diluted)
CRC
CRC
DXCM
DXCM
Q1 26
$0.67
Q4 25
$0.21
$0.67
Q3 25
$0.76
$0.70
Q2 25
$1.92
$0.45
Q1 25
$1.26
$0.27
Q4 24
$0.87
$0.37
Q3 24
$3.78
$0.34
Q2 24
$0.11
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRC
CRC
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$132.0M
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.7B
$2.7B
Total Assets
$7.4B
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRC
CRC
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$132.0M
$917.7M
Q3 25
$196.0M
$1.8B
Q2 25
$72.0M
$1.2B
Q1 25
$214.0M
$904.9M
Q4 24
$372.0M
$606.1M
Q3 24
$241.0M
$621.2M
Q2 24
$1.0B
$939.2M
Total Debt
CRC
CRC
DXCM
DXCM
Q1 26
Q4 25
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.2B
Stockholders' Equity
CRC
CRC
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$3.7B
$2.7B
Q3 25
$3.4B
$2.7B
Q2 25
$3.4B
$2.6B
Q1 25
$3.5B
$2.3B
Q4 24
$3.5B
$2.1B
Q3 24
$3.5B
$2.0B
Q2 24
$2.1B
$2.4B
Total Assets
CRC
CRC
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$7.4B
$6.3B
Q3 25
$6.8B
$7.5B
Q2 25
$6.7B
$7.3B
Q1 25
$6.8B
$6.8B
Q4 24
$7.1B
$6.5B
Q3 24
$7.1B
$6.4B
Q2 24
$4.5B
$6.8B
Debt / Equity
CRC
CRC
DXCM
DXCM
Q1 26
Q4 25
Q3 25
0.29×
Q2 25
0.30×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.32×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRC
CRC
DXCM
DXCM
Operating Cash FlowLast quarter
$235.0M
Free Cash FlowOCF − Capex
$115.0M
FCF MarginFCF / Revenue
16.9%
Capex IntensityCapex / Revenue
17.7%
Cash ConversionOCF / Net Profit
19.58×
TTM Free Cash FlowTrailing 4 quarters
$543.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRC
CRC
DXCM
DXCM
Q1 26
Q4 25
$235.0M
$294.0M
Q3 25
$279.0M
$659.9M
Q2 25
$165.0M
$303.0M
Q1 25
$186.0M
$183.8M
Q4 24
$206.0M
$301.4M
Q3 24
$220.0M
$199.5M
Q2 24
$97.0M
$279.4M
Free Cash Flow
CRC
CRC
DXCM
DXCM
Q1 26
Q4 25
$115.0M
$192.1M
Q3 25
$188.0M
$579.4M
Q2 25
$109.0M
$208.9M
Q1 25
$131.0M
$96.8M
Q4 24
$118.0M
$176.8M
Q3 24
$141.0M
$88.3M
Q2 24
$63.0M
$213.3M
FCF Margin
CRC
CRC
DXCM
DXCM
Q1 26
Q4 25
16.9%
15.3%
Q3 25
26.3%
47.9%
Q2 25
15.5%
18.1%
Q1 25
16.1%
9.3%
Q4 24
14.3%
15.9%
Q3 24
16.2%
8.9%
Q2 24
15.3%
21.2%
Capex Intensity
CRC
CRC
DXCM
DXCM
Q1 26
Q4 25
17.7%
8.1%
Q3 25
12.7%
6.7%
Q2 25
8.0%
8.1%
Q1 25
6.8%
8.4%
Q4 24
10.7%
11.2%
Q3 24
9.1%
11.2%
Q2 24
8.3%
6.6%
Cash Conversion
CRC
CRC
DXCM
DXCM
Q1 26
Q4 25
19.58×
1.10×
Q3 25
4.36×
2.33×
Q2 25
0.96×
1.69×
Q1 25
1.62×
1.74×
Q4 24
6.24×
1.99×
Q3 24
0.64×
1.48×
Q2 24
12.13×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRC
CRC

Oil And Natural Gas Segment$645.0M95%
Natural Gas Production$26.0M4%
Other$7.0M1%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons